ArticleFrontiers in pharmacology2022

Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis.

Xiaoyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.